EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inclusion body myositis, viral infections, and TDP-43: a narrative review

Vitalie Văcăraş, Romana Vulturar, Adina Chiş, Laura Damian

Clinical and Experimental Medicine · 02.05.2024 · 24 (1)

DOI: 10.1007/s10238-024-01353-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Experimental Medicine, online erschienen am 02.05.2024. Verfasst von Vitalie Văcăraş und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, "Iuliu Haţieganu" University of Medicine and Pharmacy, Cluj-Napoca, 43, Victor Babeş St, 400012, Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Myositis, Inclusion Body, Virus Diseases, DNA-Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ubiquitous RNA-processing molecule TDP-43 is involved in neuromuscular diseases such as inclusion body myositis, a late-onset acquired inflammatory myopathy. TDP-43 solubility and function are disrupted in certain viral infections. Certain viruses, high viremia, co-infections, reactivation of latent viruses, and post-acute expansion of cytotoxic T cells may all contribute to inclusion body myositis, mainly in an age-shaped immune landscape. The virally induced senescent, interferon gamma-producing cytotoxic CD8+ T cells with increased inflammatory, and cytotoxic features are involved in the occurrence of inclusion body myositis in most such cases, in a genetically predisposed host. We discuss the putative mechanisms linking inclusion body myositis, TDP-43, and viral infections untangling the links between viruses, interferon, and neuromuscular degeneration could shed a light on the pathogenesis of the inclusion body myositis and other TDP-43-related neuromuscular diseases, with possible therapeutic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myositis, Inclusion BodyVirus DiseasesDNA-Binding ProteinsHumans

Stichwörter der Autor:innen

Inclusion body myositisInterferon gammaLong COVIDMyositis triggersTDP-43

Substanzen

DNA-Binding ProteinsTARDBP protein, human

Autor:innen und Institutionen

  • Department of Neurosciences, "Iuliu Haţieganu" University of Medicine and Pharmacy, Cluj-Napoca, 43, Victor Babeş St, 400012, Cluj-Napoca, Romania.
  • Neurology Department of Cluj, County Emergency Hospital, 3-5, Clinicilor St, 400347, Cluj-Napoca, Romania.
  • Department of Molecular Sciences, "Iuliu Haţieganu" University of Medicine and Pharmacy Cluj-Napoca, 6, Pasteur St, 400349, Cluj-Napoca, Romania.
  • Cognitive Neuroscience Laboratory, University Babeş-Bolyai, 30, Fântânele St, 400294, Cluj-Napoca, Romania.
  • Association for Innovation in Rare Inflammatory, Metabolic, Genetic Diseases INNOROG, 30E, Făgetului St, 400497, Cluj-Napoca, Romania.
  • Department of Molecular Sciences, "Iuliu Haţieganu" University of Medicine and Pharmacy Cluj-Napoca, 6, Pasteur St, 400349, Cluj-Napoca, Romania. adinachis82@gmail.com.

Zitieren

APA

Văcăraş, V., Vulturar, R., Chiş, A., & Damian, L. (2024). Inclusion body myositis, viral infections, and TDP-43: a narrative review. Clinical and Experimental Medicine, 24(1). https://doi.org/10.1007/s10238-024-01353-9

Vancouver

Văcăraş V, Vulturar R, Chiş A, Damian L. Inclusion body myositis, viral infections, and TDP-43: a narrative review. Clinical and Experimental Medicine. 2024;24(1). doi:10.1007/s10238-024-01353-9

BibTeX
@article{Vcra2024,
  author = {Văcăraş, Vitalie and Vulturar, Romana and Chiş, Adina and Damian, Laura},
  title = {Inclusion body myositis, viral infections, and TDP-43: a narrative review},
  journal = {Clinical and Experimental Medicine},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1007/s10238-024-01353-9}
}
Kostenlos starten →